Segawa Masaya
Segawa Neurological Clinic for Children, Tokyo, Japan.
Chang Gung Med J. 2009 Jan-Feb;32(1):1-11.
Autosomal dominant GTP cyclohydrolase I (AD GCH 1) deficiency (Segawa disease) is an autosomal dominant dopa responsive dystonia caused by heterozygous mutation of the GCH 1 gene located on 14q22.1-q22.2. Although a number of mutations have been reported, the change remains highly stable within families, and causes a decrease in the tyrosine hydroxylase protein at the nigrostriatal (NS)-dopamine (DA) neuron terminal. In addition, decreased tetrahydrobiopterin levels early in the development affect DA receptors age-dependently, and produce a spectrum of specific symptoms attributed to neuronal changes traced to processes in the development of the NS-DA neuron, related striatal projection neurons, and the output projection of the basal ganglia.
常染色体显性遗传性GTP环化水解酶I(AD GCH 1)缺乏症(Segawa病)是一种常染色体显性遗传性多巴反应性肌张力障碍,由位于14q22.1-q22.2的GCH 1基因突变杂合子引起。虽然已报道了许多突变,但该变化在家族中保持高度稳定,并导致黑质纹状体(NS)-多巴胺(DA)神经元终末的酪氨酸羟化酶蛋白减少。此外,发育早期四氢生物蝶呤水平降低会年龄依赖性地影响DA受体,并产生一系列特定症状,这些症状归因于NS-DA神经元、相关纹状体投射神经元和基底神经节输出投射发育过程中的神经元变化。